APA

van Rooijen J. M., de Munck L., Teeuwen G. M., de Graaf J. C., Jansman F. G., Boers J. E. & Siesling S. (20160523). Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. : Anti-cancer drugs.

Chicago

van Rooijen Johan M, de Munck Linda, Teeuwen Guusje M, de Graaf Jacques C, Jansman Frank G, Boers James E and Siesling Sabine. 20160523. Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. : Anti-cancer drugs.

Harvard

van Rooijen J. M., de Munck L., Teeuwen G. M., de Graaf J. C., Jansman F. G., Boers J. E. and Siesling S. (20160523). Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. : Anti-cancer drugs.

MLA

van Rooijen Johan M, de Munck Linda, Teeuwen Guusje M, de Graaf Jacques C, Jansman Frank G, Boers James E and Siesling Sabine. Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. : Anti-cancer drugs. 20160523.